有晶状体眼后房型人工晶状体植入术治疗超高度近视的临床研究

Clinical effects of phakic posterior chamber intraocular lens implantation for very high myopia

观察分析有晶状体眼后房型人工晶状体植入术（ ICL）治疗超高度近视的临床疗效。方法选择分析我院2011年6月至2013年6月行有晶状体眼后房型人工晶状体植入术治疗超高度近视患者14例（25只眼）。术前常规检查视力、最佳矫正视力，进行各项检查后，行单眼或者双眼有晶状体眼后房型人工晶状体植入术，术后观察视力、眼压及内皮细胞计数变化情况。结果术后视力0．3-1．0。术后2例（3只眼）出现早期眼压升高，经降眼压治疗，3-4 d后眼压正常。结论有晶状体眼后房型人工晶状体植入术治疗超高度近视及散光疗效确切，患者满意度好，预测性好，手术安全。

Objective To analyse the clinical efficacy of phakic posterior chamber intraocular lens implantation （ICL） for treatment of very high myopia .Methods Totally 14 patients （ 25 eyes） with phakic posterior chamber intraoc-ular lens implantation were analysed from June 2011 to June 2013.Routine visual acuity ,best-corrected visual acuity and various important examinations were performed preoperatively for phakic posterior chamber intraocular lens implantation . Results Postoperative visual acuity was 0.3 to 1.0.Complications were secondary glaucoma .3 eyes of 2 patients had in-creased intraocular pressure shortly after surgery .After treatment, the intraocular pressure became normal in 3 to 4 days. Conclusion The phakic posterior chamber IOL was efficacious , predictable and safe .